Real World, Open Label, QOL Assessment of Peanut Immunotherapy AR101 in Children and Adolescents
Clinical trial NCT03703791 · TERMINATED
Trial details
- NCT number
- NCT03703791
- Sponsor
- Aimmune Therapeutics, Inc.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-24
- Primary completion
- 2018-11-23
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.